Cogent Biosciences Inc (COGT)

SG&A Expenses

$31.83M

Quarterly · Period ending: · USD

COGT logo

COGT SG&A Expenses

Latest reported$31.83M
COGT Quarterly SG&A Expenses ($4.70M → $31.83M)
High-resolution chart · PNG

COGT sg&a expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Cogent Biosciences Inc SG&A Expenses — Quarterly (USD)
Period endingSG&A Expenses (USD)
31,827,000
28,242,000
23,934,000
14,366,000
13,379,000
11,904,000
11,689,000
11,800,000
10,093,000
9,699,000
9,509,000
9,453,000
8,214,000
7,199,000
7,003,000
6,885,000
6,376,000
5,948,000
5,126,000
5,021,000
4,904,000
4,587,000
5,348,000
5,598,000
2,802,000
3,674,000
2,694,000
2,721,000
3,062,000
2,491,000
2,044,000
2,367,000
1,979,000
1,064,000
1,441,000
1,324,000
971,000
944,000
21,368,000
4,702,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.